ChainPeptides

ChainPeptides Oy develops the Chain Smart Plaster™, a first-in-class biosensor + antimicrobial peptide platform for diabetic foot ulcer management. Embedded sensors monitor pH, temperature, moisture and pressure in real-time, alerting clinicians before infection becomes limb-threatening. A second generation adds controlled-release AMPs effective against MRSA and drug-resistant pathogens, addressing a $6B+ annual care burden and preventing the progression from chronic wound to amputation.

  • Category: Medtech
  • Customer segment: B2B
  • Development stage: MVP / Preclinical
  • Funding stage: Pre-seed
  • Founding year: 2022
  • Team members: 5